Form 4: DexCom Director Renee D. Gala Reports Stock Transactions

Director Renee D. Gala reports acquisition of 5,074 shares of DexCom stock and disposal of shares to cover taxes.

Summary

• Renee D. Gala, a director of DexCom Inc., filed a Form 4 disclosing changes in beneficial ownership.
• On May 8, 2025, Gala acquired 5,074 shares of DexCom common stock as part of a restricted stock unit (RSU) award.
• The RSU award vests 100% on the earlier of the one-year anniversary of the grant date or the date of DexCom's 2026 Annual Meeting of Stockholders.
• Gala also disposed of shares, the price of which was $0.
• Following the reported transactions, Gala beneficially owns 10,794 shares, including unvested restricted stock units.
• 5,720 of the unvested restricted stock units were granted on March 6, 2025, and vest through March 6, 2028.
• The remaining 5,074 unvested restricted stock units were granted on May 8, 2025, and vest on the earlier of the one-year anniversary of the grant date or the date of DexCom's 2026 Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock transactions by a company director. The acquisition of shares is a mildly positive signal.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units indicates a long-term commitment by the director to the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the director's continued investment in the company.

Stakeholder Impact

• The disclosure provides transparency to shareholders regarding the director's stock ownership.

Key Dates

Keywords

Form 4, beneficial ownership, DexCom, DXCM, Renee D. Gala, restricted stock units, RSU, director